Dr Damjana Bogatic
School of Medicine
College of Health
| Date | Position | Institution name |
|---|---|---|
| 2024 - ongoing | Inflammatory Bowel Disease Fellow | Queen Elizabeth Hospital |
| 2024 - ongoing | Higher Degree by Research Candidate | University of Adelaide |
| Date | Institution name | Country | Title |
|---|---|---|---|
| 2020 | University of Newcastle Australia | Australia | Master of Public Health with Distinction |
| 2018 | Flinders University | Australia | Doctor of Medicine |
| 2013 | Flinders University | Australia | Bachelor of Medical Science |
| Year | Citation |
|---|---|
| 2025 | Chu, M. K. W., Day, A. S., Bogatic, D., Hatzi, M., Chu, S. K. S., Costello, S. P., & Bryant, R. V. (2025). Frequent Dietetic Involvement Enhances Adherence and Clinical Outcomes of Exclusive Enteral Nutrition in Adults With Crohn's Disease. Jgh Open, 9(7), 14 pages. |
| 2025 | Bogatic, D., Sparrow, M. P., Boyapati, R. K., & Bryant, R. V. (2025). Balancing costs and care: evaluating the need for novel therapies for immune-mediated inflammatory diseases in Australia. Internal Medicine Journal, 6 pages. |
| 2024 | Bogatic, D., & Bryant, R. V. (2024). Letter: Microbial manipulation for primary sclerosing cholangitis-associated inflammatory bowel disease—hope on the horizon. Alimentary Pharmacology and Therapeutics, 60(4), 535-536. |
| 2024 | Bogatic, D., & Bryant, R. V. (2024). Letter: Gut microbiota—An overlooked therapeutic target in the prevention of post-operative recurrence of Crohn's disease. Alimentary Pharmacology and Therapeutics, 60(10), 1501-1502. |
| 2023 | Bogatic, D., Bryant, R. V., Lynch, K. D., & Costello, S. P. (2023). Cover Image. Alimentary Pharmacology & Therapeutics, 57(1). |
| 2022 | Loo, K. F., Woodman, R. J., Bogatic, D., Chandran, V., Muller, K., Chinnaratha, M. A., . . . Wigg, A. (2022). High rates of treatment stage migration for early hepatocellular carcinoma and association with adverse outcomes: an Australian multicenter study. JGH Open, 6(9), 599-606. Scopus2 WoS2 Europe PMC3 |
| 2022 | Bogatic, D., Bryant, R. V., Lynch, K. D., & Costello, S. P. (2022). Microbial manipulation as therapy for primary sclerosing cholangitis. Alimentary Pharmacology and Therapeutics, 57(1), 23-36. Scopus13 WoS12 Europe PMC10 |
| Year | Citation |
|---|---|
| 2025 | Chu, M., Day, A. S., Bogatic, D., Hatzi, M., Chu, S. K., Costello, S. P., & Bryant, R. (2025). Early dietetic assessment predicts clinical efficacy of Exclusive Enteral Nutrition in adults with Crohn's disease. In JOURNAL OF CROHNS & COLITIS Vol. 19 (pp. I1427). OXFORD UNIV PRESS. DOI |
| 2024 | Theron, C., Bryant, R., Bogatic, D., & Day, A. (2024). Systematic scoping review: dietary interventions for the treatment of primary sclerosing cholangitis. In JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY Vol. 39 (pp. 315-316). WILEY. |
| 2024 | Bogatic, D., Mathias, R. M., Bryant, R., Day, A., & Plush, S. (2024). Intestinal ultrasound supports safety in a clinic for functional gastrointestinal disorders. In JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY Vol. 39 (pp. 251-252). WILEY. |
| Year | Citation |
|---|---|
| 2020 | Loo, K. F., Woodman, R., Bogatic, D., Muller, K., Chandran, V., Chinnaratha, M. A., . . . Wigg, A. (2020). TREATMENT STAGE MIGRATION FOR EARLY HCCs AND ITS IMPACT ON OUTCOMES- A MULTI-CENTRE STUDY. Poster session presented at the meeting of HEPATOLOGY. ELECTR NETWORK: WILEY. WoS1 |
| 2020 | Loo, K. F., Woodman, R., Bogatic, D., Muller, K., Chandran, V., Chinnaratha, M. A., . . . Wigg, A. (2020). Treatment stage migration for early hepatocellular carcinoma and its impact on outcomes: A multicenter study. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY. WoS1 |
Connect With Me
External Profiles
